🇺🇸 FDA
Pipeline program

temsirolimus

3066K1-4438

Approved small_molecule completed

Quick answer

temsirolimus for Non-Hodgkin's Lymphoma is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
Non-Hodgkin's Lymphoma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials